133 related articles for article (PubMed ID: 38016686)
21. Routine pre-operative ultrasonography for papillary thyroid cancer: effects on cervical recurrence.
Marshall CL; Lee JE; Xing Y; Perrier ND; Edeiken BS; Evans DB; Grubbs EG
Surgery; 2009 Dec; 146(6):1063-72. PubMed ID: 19958933
[TBL] [Abstract][Full Text] [Related]
22. Preoperative Ultrasonographic Staging of Papillary Thyroid Carcinoma With the Eighth American Joint Committee on Cancer Tumor-Node-Metastasis Staging System.
Zhang J; Fei M; Dong Y; Xu S; Zhan W
Ultrasound Q; 2020 Jun; 36(2):158-163. PubMed ID: 31478984
[TBL] [Abstract][Full Text] [Related]
23. Prognostic implications of extranodal extension in papillary thyroid carcinomas: A propensity score matching analysis and proposal for incorporation into current tumor, lymph node, metastasis staging.
Genpeng L; Pan Z; Tao W; Rixiang G; Jingqiang Z; Zhihui L; Jianyong L
Surgery; 2022 Feb; 171(2):368-376. PubMed ID: 34482990
[TBL] [Abstract][Full Text] [Related]
24. Preoperative lateral neck ultrasonography as a long-term outcome predictor in papillary thyroid cancer.
Moreno MA; Agarwal G; de Luna R; Siegel ER; Sherman SI; Edeiken-Monroe BS; Clayman GL
Arch Otolaryngol Head Neck Surg; 2011 Feb; 137(2):157-62. PubMed ID: 21339402
[TBL] [Abstract][Full Text] [Related]
25. Roles of ultrasonography and computed tomography in the surgical management of cervical lymph node metastases in papillary thyroid carcinoma.
Lee DW; Ji YB; Sung ES; Park JS; Lee YJ; Park DW; Tae K
Eur J Surg Oncol; 2013 Feb; 39(2):191-6. PubMed ID: 22863305
[TBL] [Abstract][Full Text] [Related]
26. Real-World Evidence on the Sensitivity of Preoperative Ultrasound in Evaluating Central Lymph Node Metastasis of Papillary Thyroid Carcinoma.
Yao F; Yang Z; Li Y; Chen W; Wu T; Peng J; Jiao Z; Yang A
Front Endocrinol (Lausanne); 2022; 13():865911. PubMed ID: 35757396
[TBL] [Abstract][Full Text] [Related]
27. Lobectomy Is Feasible for 1-4 cm Papillary Thyroid Carcinomas: A 10-Year Propensity Score Matched-Pair Analysis on Recurrence.
Song E; Han M; Oh HS; Kim WW; Jeon MJ; Lee YM; Kim TY; Chung KW; Kim WB; Shong YK; Hong SJ; Sung TY; Kim WG
Thyroid; 2019 Jan; 29(1):64-70. PubMed ID: 30375260
[TBL] [Abstract][Full Text] [Related]
28. Impact of preoperative ultrasonographic staging of the neck in papillary thyroid carcinoma.
González HE; Cruz F; O'Brien A; Goñi I; León A; Claure R; Camus M; Dominguez F; Mosso L; Arteaga E; González G; López JM; Rodriguez JA; Carrasco C; Fardella C
Arch Otolaryngol Head Neck Surg; 2007 Dec; 133(12):1258-62. PubMed ID: 18086969
[TBL] [Abstract][Full Text] [Related]
29. [Prediction and investigation of the potential risk factors for the upper mediastinal metastasis of papillary thyroid carcinoma].
Liu Y; Xu SY; Liu K; Wang XL; Liu SY; Xu ZG; Liu J
Zhonghua Zhong Liu Za Zhi; 2021 Apr; 43(4):477-483. PubMed ID: 33902211
[No Abstract] [Full Text] [Related]
30. Coexistence of papillary thyroid carcinoma in secondary hyperparathyroidism.
Ma J; Mao Z; Yao Y; Lu Y; Wang H; Yang Y; Yang J; Wang W; Teng L
BMC Surg; 2021 Sep; 21(1):335. PubMed ID: 34488715
[TBL] [Abstract][Full Text] [Related]
31. Extranodal extension of metastatic papillary thyroid carcinoma: correlation with biochemical endpoints, nodal persistence, and systemic disease progression.
Lango M; Flieder D; Arrangoiz R; Veloski C; Yu JQ; Li T; Burtness B; Mehra R; Galloway T; Ridge JA
Thyroid; 2013 Sep; 23(9):1099-105. PubMed ID: 23421588
[TBL] [Abstract][Full Text] [Related]
32. Comparison of Lobectomy vs Total Thyroidectomy for Intermediate-Risk Papillary Thyroid Carcinoma With Lymph Node Metastasis.
Xu S; Huang H; Huang Y; Qian J; Wang X; Xu Z; Liu S; Liu J
JAMA Surg; 2023 Jan; 158(1):73-79. PubMed ID: 36449303
[TBL] [Abstract][Full Text] [Related]
33. Clinical outcomes of ultrasound-guided radiofrequency ablation for solitary T1N0M0 papillary thyroid carcinoma: A retrospective study with more than 5 years of follow-up.
Yan L; Li Y; Li XY; Xiao J; Tang J; Luo Y
Cancer; 2023 Aug; 129(16):2469-2478. PubMed ID: 37060239
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of microwave ablation for the treatment of multifocal versus unifocal T1N0M0 papillary thyroid carcinoma: a propensity-matched multicentre retrospective study.
Zhao ZL; Dong G; Wang SR; Liu Y; He JF; Shi LL; Guo JQ; Wang ZH; Cong ZB; Liu LH; Yang BB; Qu CP; Wei Y; Peng LL; Li Y; Lu NC; Wu J; Yu MA
Eur Radiol; 2023 Dec; 33(12):8727-8735. PubMed ID: 37466709
[TBL] [Abstract][Full Text] [Related]
35. Preoperative prognostic risk stratification model for papillary thyroid carcinoma based on clinical and ultrasound characteristics.
Shen K; Xiao S; Wu X; Zhang G
Front Endocrinol (Lausanne); 2022; 13():1025739. PubMed ID: 36277684
[TBL] [Abstract][Full Text] [Related]
36. Features of lymph node metastasis of papillary thyroid carcinoma in ultrasonography and CT and the significance of their combination in the diagnosis and prognosis of lymph node metastasis.
Wei Q; Wu D; Luo H; Wang X; Zhang R; Liu Y
J BUON; 2018; 23(4):1041-1048. PubMed ID: 30358209
[TBL] [Abstract][Full Text] [Related]
37. Risk Factors Associated With Recurrence and Death in Patients With Tall Cell Papillary Thyroid Cancer: A Single-Institution Cohort Study With Predictive Nomogram.
Wu SS; Joshi N; Sharrett J; Rao S; Shah A; Scharpf J; Burkey B; Lamarre ED; Prendes B; Siperstein A; Shin J; Berber E; Jin J; Krishnamurthi V; Nasr C; Hong L; Buchberger DS; Woody N; Koyfman SA; Geiger JL
JAMA Otolaryngol Head Neck Surg; 2023 Jan; 149(1):79-86. PubMed ID: 36454559
[TBL] [Abstract][Full Text] [Related]
38. Does preoperative neutrophil lymphocyte ratio predict risk of recurrence and occult central nodal metastasis in papillary thyroid carcinoma?
Lang BH; Ng CP; Au KB; Wong KP; Wong KK; Wan KY
World J Surg; 2014 Oct; 38(10):2605-12. PubMed ID: 24809487
[TBL] [Abstract][Full Text] [Related]
39. A novel RNA sequencing-based risk score model to predict papillary thyroid carcinoma recurrence.
He J; Tian Z; Yao X; Yao B; Liu Y; Yang J
Clin Exp Metastasis; 2020 Apr; 37(2):257-267. PubMed ID: 31792675
[TBL] [Abstract][Full Text] [Related]
40. Is surgical resection without radioactive iodine treatment a safe alternative treatment for T1-2N1bM0 papillary thyroid carcinoma?
Fujiwara T; Yoshizawa A; Mizuta M; Tamaki H
Auris Nasus Larynx; 2021 Feb; 48(1):148-153. PubMed ID: 32718811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
